Press release
30 July 2022
Embargo till 08:00h CET
FINANCIERE DE TUBIZE SA
Allée de la Recherche 60, 1070 Brussels
Contact: Eric Nys, day-to-day management, eric.nys@financiere-tubize.be
2022 half-year financial report
Regulated information
30 July 2022
The board of directors of Financière de Tubize has issued the 2022 half-year financial report. This report is available on the website www.financiere-tubize.be
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…